Medical Substitution Supply (Per RANK 01 Hierarchy)

The contract governs the supply of authorized substitute pharmaceuticals when primary medications are unavailable, strictly adhering to the DLA RANK 01 substitution hierarchy and required medical necessity criteria. It ensures continuity of care for military and veterans' health programs by permitting approved alternatives only when clinically justified and aligned with established procurement protocols, maintaining safety and efficacy standards without compromising treatment outcomes. Issued by the Defense Logistics Agency under the Department of Defense, this subcontract is classified under NAICS code 424210 for pharmaceutical and botanical product merchant wholesalers. The agreement is active as of July 15, 2026, and operates under contract SPE2DX25D8022 with delivery order SPE2D926F7351. Performance is expected to support nationwide defense health system needs, with all substitutions governed by federal and DLA-mandated guidelines to ensure compliance, accountability, and clinical appropriateness across all issued pharmaceutical replacements.